◉ HEADLINES

Pharmaniaga

Pharmaniaga records 3Q net profit of RM101.03 mln

Revenue increased by 16.3% to RM1.03 billion in 3Q from RM885.49 million previously, primarily driven by the increased demand in the concession segment

Auditor casts doubt on Pharmaniaga ability as going concern

As of Dec 31, 2023, the group and company’s current liabilities exceeded their current assets

Pharmaniaga to raise RM654.6 mil in bid to exit PN17 status

Pharmaniaga Bhd has submitted its regularisation plan to Bursa Malaysia Securities Bhd as the company bids to exit its PN17 status.

Pharmaniaga tandatangan perjanjian konsensi dengan KKM selama tujuh tahun

Pharmaniaga Logistics Sdn Bhd (PLSB) iaitu anak syarikat milik penuh Pharmaniaga Berhad (Pharmaniaga) telah mencapai Perjanjian Konsensi (CA) dengan Kementerian Kesihatan (KKM) untuk membekalkan perkhidmatan bekalan perubatan.

Laporan PAC mengenai perolehan ventilator cetus lebih banyak persoalan berbanding jawapan: MMA

Persatuan Perubatan Malaysia (MMA) menegaskan perlu ada akauntabiliti lengkap atas kekurangan dokumentasi dalam perolehan ventilator yang didedahkan oleh Jawatankuasa Kira-kira Wang Negara (PAC), semalam
Load more

◉ Popular

Apad confirms inDrive licence revoked effective July 24, but company can appeal

Russian-based company can file appeal through the agency for the Transport Ministry's consideration

RM200m World Cup rights fee puts Malaysia’s 2026 viewing at risk

Malaysia could miss live coverage of the 2026 FIFA World Cup as a steep RM200 million broadcasting fee strains Astro and RTM, raising doubts over whether fans will be able to watch football’s biggest tournament

More than 100 Foodpanda riders protest over low wages at company headquarters

New Google Maps-based system forces riders to make more deliveries to make ends meet

Copyright © 2023. All rights reserved.